Ian Milsom

STUDY QUESTION: Does intrauterine contraception influence the prevalence and severity of dysmenorrhea? SUMMARY ANSWER: In this longitudinal study, a copper intrauterine device (Cu-IUD) did not influence the severity of dysmenorrhea, wherea…

This issue of Acta Obstetricia Gynecologica Scandinavica contains new guidelines for the management of menorrhagia recommended by the Finnish Society of Obstetrics and Gynecology. The treatment of menorrhagia has undergone radical changes o…

BACKGROUND: Recent studies have indicated that the risk of thromboembolic disease (VTE) in users of combined oral contraceptive pills (COCs) varies not only with estrogen dose, but also with the progestogen in pills with the same estrogen d…

Objective: To investigate factors possibly associated with endometrial thickness and uterine size in a random sample of postmenopausal women. Study design: A random sample ( n = 1000) of the total population of women aged 45–80 years reside…

ObjectiveThe objective of this study was to investigate factors possibly associated with endometrial thickness and uterine size in a random sample of postmenopausal women.Study designA random sample (n = 1000) of the total population of wom…

Treatment with flurbiprofen (100 mg twice a day for 5 days), tranexamic acid (1.5 gm three times a day for 3 days and 1 gm twice a day for another 2 days), and an intrauterine contraceptive device releasing 20 micrograms levonorgestrel per …

The effect of flurbiprofen (100 mg × 2 for 5 days) was compared with tranexamic acid (1.5 g × 3 for 3 days, 1 g × 2 days 4 and 5) in the treatment of 15 women with idiopathic menorrhagia. The mean blood loss during two medication‐free perio…

The effects of flurbiprofen (100 mg) and naproxen sodium (500 mg) on intrauterine pressure and menstrual pain were assessed in 8 women with primary dysmenorrhea using a double-blind parallel study technique. Intrauterine pressure was record…